ATHEROGENIC EFFECTS OF ANABOLIC-STEROIDS ON SERUM-LIPID LEVELS - A LITERATURE-REVIEW

被引：171
作者：
GLAZER, G
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 1991年 / 151卷 / 10期
关键词：
D O I：
10.1001/archinte.151.10.1925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article reviews the current body of literature linking anabolic steroids to atherogenic alterations in serum lipid levels. Anabolic steroids cause marked high-density lipoprotein level depression (weighted average, 52%) and severe depression of high-density lipoprotein(b) levels (weighted average, 78%) while raising low-density lipoprotein levels an average of 36%. The mechanism of these lipid changes, their time course in relation to anabolic steroid use, and their dependency on route of anabolic steroid administration are discussed. Interpretation of the observed lipid level changes in light of the epidemiologic data linking lipids to coronary heart disease risk is used to estimate the lipid-based increase in coronary heart disease risk due to anabolic steroid use.
引用
收藏
页码：1925 / 1933
页数：9
相关论文
共 70 条
[1]   REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J].
ALBERS, JJ ;
TAGGART, HM ;
APPLEBAUMBOWDEN, D ;
HAFFNER, S ;
CHESNUT, CH ;
HAZZARD, WR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) :293-296
[2]   REDUCED HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL IN POWER ATHLETES - USE OF MALE SEX-HORMONE DERIVATES, AN ATHEROGENIC FACTOR [J].
ALEN, M ;
RAHKILA, P .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1984, 5 (06) :341-342
[3]   EFFECT OF ESTROGEN ON POST-HEPARIN LIPOLYTIC-ACTIVITY - SELECTIVE DECLINE IN HEPATIC TRIGLYCERIDE LIPASE [J].
APPLEBAUM, DM ;
GOLDBERG, AP ;
PYKALISTO, OJ ;
BRUNZELL, JD ;
HAZZARD, WR .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (04) :601-608
[4]   THE DYSLIPOPROTEINEMIA OF ANABOLIC-STEROID THERAPY - INCREASE IN HEPATIC TRIGLYCERIDE LIPASE PRECEDES THE DECREASE IN HIGH-DENSITY LIPOPROTEIN2 CHOLESTEROL [J].
APPLEBAUMBOWDEN, D ;
HAFFNER, SM ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (10) :949-952
[5]   HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN CONTROL SUBJECTS [J].
BALLANTYNE, FC ;
CLARK, RS ;
SIMPSON, HS ;
BALLANTYNE, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :433-437
[6]  
BROWER KJ, 1989, J CLIN PSYCHIAT, V50, P31
[7]  
BUSH TL, 1988, CLIN CHEM, V34, pB60
[8]   HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772
[9]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[10]   HIGH-DENSITY LIPOPROTEINS DURING HYPOLIPIDEMIC THERAPY - COMPARATIVE-STUDY OF 4 DRUGS [J].
CHEUNG, MC ;
ALBERS, JJ ;
WAHL, PW ;
HAZZARD, WR .
ATHEROSCLEROSIS, 1980, 35 (03) :215-228
1234567